Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 
Commentary | 2022
Decriminalization/legalization, Hallucinogens/psychedelics, Policy/Regulatory

We examined measures of drug enforcement as predictors of next-year fatal overdose rates in the Washington/Baltimore High Intensity Drug Trafficking Area (W/B HIDTA).

Original research | 2022
Legal system/law enforcement, Overdose, Mortality, Outcomes, Illegal drugs

This paper explores the narratives of service users of contemporary methadone maintenance treatment services (MMT) in the Republic of Ireland to obtain their perspectives in the context of them neg

Original research | 2022
Substitution/OAT, About PWUD, Barriers and enablers

To investigate whether low barrier MOUD improved retention in care compared to traditional treatment.

Original research | 2022
Barriers and enablers, About PWUD, Substitution/OAT

We test a conceptual model that emphasizes indirect, mediated effects among key factors related to HIV testing in substance use disorder treatment organizations (SUTs), a critical evidence-based pr

Original research | 2022
Evidence base, Wrap-around services
Page Web | 2022
la politique / le cadre de réglementation

This study aimed to determine the feasibility and safety of a tapering dose of lisdexamfetamine for the treatment of acute methamphetamine (MA) withdrawal.

Original research | 2022
Stimulants, Withdrawal, Clinical guidance

We explored whether patients with benzodiazepine exposure at treatment entry would have similar 12-month retention compared to those without benzodiazepine exposure.

Original research | 2022
Substitution/OAT, Clinical guidance

The therapeutic benefits of cannabinoids remain unclear, especially when weighted against their adverse effects.

Lit review | 2022
Withdrawal, Clinical guidance

This study sought to characterize the gap in OAT treatment using a cascade of care framework, and determine factors associated with engagement and retention in treatment.

Original research | 2022
About PWUD, Substitution/OAT, Sex/Gender , Mental health, Rural/remote, Outcomes

This review of clinical research reports the evidence regarding biomedical and behavioral treatments for psychostimulant withdrawal symptoms.

Lit review | 2022
Withdrawal, Stimulants, Clinical guidance

This study sought to characterize the prevalence and correlates of having difficulty accessing SCS during the COVID-19 pandemic among people who use drugs in Vancouver, Canada.

Original research | 2022
SCS/OPS, About PWUD, Equity, Barriers and enablers
Commentary | 2022
About prescribers

To explore the similarities and differences of organization-based and informal spotting (remote supervision of substance use) from the perspectives of spotters and spottees across Canada.

Original research | 2023
Harm reduction, Digital health, About PWUD

We investigated whether depiction of the characteristics of decedents represented in news articles about drug related deaths (DRD) was associated with differences in stigmatising attitudes and supp

Original research | 2023
Harm reduction, Stigma, Mortality

Drawing on qualitative interviews and ethnographic fieldwork with actors engaged in an Australian illicit drug policy reform campaign, this paper examines how particular modes of personal connectio

Original research | 2022
Policy/Regulatory, Advocacy, Equity

This study examines public attitudes towards the punishment of medical cannabis (MC) diversion in Israel.

Original research | 2022
Diversion

This observational prospective study aimed to determine whether duration to the earning of privileges of “take-home” methadone doses (as a part of behavioral enforcement) reflects long-term outcome

Original research | 2011
Carries/take-home doses, About PWUD, Substitution/OAT, Outcomes

Affiner votre recherche

Mots clés
Format
Région